The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Abstract
Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes. Mice deficient in IRF4 showed normal distribution of B and T lymphocyes at 4 to 5 weeks of age but developed progressive generalized lymphadenopathy. IRF4-deficient mice exhibited a profound reduction in serum immunoglobulin concentrations and did not mount detectable antibody responses. T lymphocyte function was also impaired in vivo; these mice could not generate cytotoxic or antitumor responses. Thus, IRF4 is essential for the function and homeostasis of both mature B and mature T lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Mittrucker et al., 1997
In the citing paper
“whereas PIP function is necessary for maturation of B and T lymphocytes (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“whereas PIP−/− animals exhibit a block in peripheral maturation of B cells and fail to produce antibodies in response to antigenic stimulation.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“Similarly, T cells of the mutant animals (PIP−/−) lack proliferative and cytotoxic responses (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
Citations
Cites
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,258
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843
Self-citationTanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationBetz, A. G., Milstein, C., González‐Fernández, Á., Pannell, R., Larson, T., & Neuberger, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90316-6 · Cited by 379
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Transitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2129 · Cited by 358
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Flagged first, then by citations
Research works printed but not linked: 4
- Lamphier M., Taniguchi T., Immunologist 2, 167 (1994);
- Vaughan P. S., et al., ibid. 377, 362 (1995);
- Schmits R., et al., ibid., p. 1415.
- Healthy 5- to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann G. Boehmelt G. Duncan D. Ferrick C. Furlonger D. Kägi F. Kiefer L. Marengere C. Paige J. Penninger M. Saunders R. Schmits D. Siderovski D. Speiser S. Yoshinaga and P. Waterhouse for providing reagents and for helpful comments.
Cited by
Sorted by citations
Items 201–300 of 583
IRF4 in multiple myeloma—Biology, disease and therapeutic target
Agnarelli, A., Chevassut, T. J. T., & Mancini, E. J. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.07.025 · Cited by 75
Holodick, N. E., Tumang, J. R., & Rothstein, T. L. (2010) · European Journal of Immunology · doi:10.1002/eji.201040545 · Cited by 76
Transcriptional regulation of B-cell differentiation
Reya, T., & Grosschedl, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80244-6 · Cited by 76
Rosenbauer, F., Waring, J. F., Foerster, J., Wietstruk, M., Philipp, D., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.12.4274 · Cited by 76
Shimbo, K., Hsu, G. W., Nguyen, H. C. X., Mahrus, S., Trinidad, J. C., Burlingame, A. L., & Wells, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208616109 · Cited by 72
Xu, D., Zhao, L., Valle, L. D., Miklossy, J., & Zhang, L. (2008) · Journal of Virology · doi:10.1128/jvi.00163-08 · Cited by 76
Transcriptional control of B cell development and function
Bartholdy, B., & Matthias, P. (2003) · Gene · doi:10.1016/j.gene.2003.11.008 · Cited by 78
Sasaki, K., Terker, A. S., Pan, Y., Li, Z., Cao, S., Wang, Y., Niu, A., Wang, S., Fan, X., Zhang, M., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071010 · Cited by 73
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5
Wies, E., Hahn, A. S., Schmidt, K. M., Viebahn, C., Rohland, N., Lux, A., Schellhorn, T., Holzer, A., Jung, J. U., & Neipel, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809252200 · Cited by 73
IRF4 haploinsufficiency in a family with Whipple’s disease
Guérin, A., Kerner, G., Marr, N., Markle, J., Fenollar, F., Wong, N., Boughorbel, S., Avery, D. T., Ma, C. S., Bougarn, S., et al. (2018) · eLife · doi:10.7554/elife.32340 · Cited by 75
Lassen, S., Lech, M., Römmele, C., Mittruecker, H., Mak, T. W., & Anders, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904207 · Cited by 71
Self-citationBiswas, P. S., Gupta, S. K., Stirzaker, R. A., Kumar, V. V., Jessberger, R., Lu, T. T., Bhagat, G., & Pernis, A. B. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111195 · Cited by 76
Primary cutaneous anaplastic large cell lymphoma
Brown, R. A., Fernandez‐Pol, S., & Kim, J. (2017) · Journal of Cutaneous Pathology · doi:10.1111/cup.12937 · Cited by 71
Pitha, P. M., Au, W. C., Lowther, W. J., Juang, Y.-T., Schafer, S. L., Burýšek, L., Hiscott, J. B., & Moore, P. A. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80018-2 · Cited by 71
Kim, D. W., Kim, D. W., Chang, W., Choe, J., Kim, J., Park, C.-S., Song, K., & Lee, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102297 · Cited by 70
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
Pang, S. H. M., Minnich, M., Gangatirkar, P., Zheng, Z., Ebert, A., Song, G., Dickins, R. A., Corcoran, L. M., Mullighan, C. G., Busslinger, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.27 · Cited by 69
Nitric oxide enhances Th9 cell differentiation and airway inflammation
Niedbała, W., Besnard, A., Nascimento, D. C., Donate, P. B., Sônego, F., Yip, E., Guabiraba, R., Chang, H., Fukada, S. Y., Salmond, R. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5575 · Cited by 72
Mondala, P. K., Vora, A. A., Zhou, T., Lazzari, E., Ladel, L., Luo, X., Kim, Y., Costello, C. L., MacLeod, A. R., Jamieson, C. H. M., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2020.12.017 · Cited by 70
Carbone, A., Gloghini, A., Cozzi, M. R., Capello, D., Steffan, A., Monini, P., Marco, L. D., & Gaïdano, G. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02329.x · Cited by 67
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 68
Nagulapalli, S., & Atchison, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4639 · Cited by 66
Simonetti, G., Carette, A., Silva, K., Wang, H., Silva, N. S. D., Heise, N., Siebel, C. W., Shlomchik, M. J., & Klein, U. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131026 · Cited by 71
Gene expression profiling in human gastric mucosa infected with Helicobacter pylori
Hofman, V., Moreilhon, C., Brest, P., Lassalle, S., Lebrigand, K., Sicard, D., Raymond, J., Lamarque, D., Hébuterne, X., Mari, B. P., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800930 · Cited by 65
CD4–CD8 differentiation in the thymus: connecting circuits and building memories
Xiong, Y., & Bosselut, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.02.002 · Cited by 65
Lehtonen, A., Lund, R., Lahesmaa, R., Julkunen, I., Sareneva, T., & Matikainen, S. (2003) · Cytokine · doi:10.1016/j.cyto.2003.07.001 · Cited by 69
Microarray‐based understanding of normal and malignant plasma cells
Vos, J. D., Hose, D., Reme, T. X., Tarte, K., Moreaux, J., Mahtouk, K., Jourdan, M., Goldschmidt, H., Rossi, J., Cremer, F. W., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00362.x · Cited by 65
Belz, G. T., & Kallies, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.03.008 · Cited by 64
Differential requirement for OBF-1 during antibody-secreting cell differentiation
Corcoran, L. M., Hasbold, J., Dietrich, W., Hawkins, E. D., Kallies, A., Nutt, S. L., Tarlinton, D. M., Matthias, P., & Hodgkin, P. D. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042325 · Cited by 64
Regulatory events in early and late B-cell differentiation
Johnson, K., Shelef, M. A., Tunyaplin, C., & Calame, K. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.039 · Cited by 64
Richards, J. O., Naour, F. L., Hanash, S., & Beretta, L. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb05944.x · Cited by 64
Regulatory mechanisms of B cell responses and the implication in B cell-related diseases
Tsai, D.-Y., Hung, K.-H., Chang, C., & Lin, K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0558-1 · Cited by 70
IRF4 and IRF8: governing the virtues of B lymphocytes
Shukla, V., & Lu, R. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1318-y · Cited by 70
The interferon-alpha revival in CML
Talpaz, M., Mercer, J., & Hehlmann, R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2326-y · Cited by 64
Grammer, A. C., & Lipsky, P. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10287 · Cited by 62
Review: The Role of IRF-4 in B and T Cell Activation and Differentiation
Pernis, A. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452728 · Cited by 63
Thuy, N. B. T., Ucisik-Akkaya, E., Davis, C. F., Morrison, B. A., & Dorak, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.015 · Cited by 60
Cook, A. D., Lee, M.-C., Saleh, R., Khiew, H. W., Christensen, A. D., Achuthan, A. A., Fleetwood, A. J., Lacey, D. C., Smith, J. E., Förster, I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99249 · Cited by 60
Sharma, S., Grandvaux, N., Mamane, Y., Génin, P., Azimi, N., Waldmann, T. A., & Hiscott, J. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3120 · Cited by 61
IRF-4 functions as a tumor suppressor in early B-cell development
Acquaviva, J., Chen, X., & Ren, R. (2008) · Blood · doi:10.1182/blood-2007-10-117838 · Cited by 59
IRF4 mutations in chronic lymphocytic leukemia
Havelange, V., Pekarsky, Y., Nakamura, T., Palamarchuk, A., Alder, H., Rassenti, L. Z., Kipps, T. J., & Croce, C. M. (2011) · Blood · doi:10.1182/blood-2011-04-350579 · Cited by 59
IRF4 Deficiency Abrogates Lupus Nephritis Despite Enhancing Systemic Cytokine Production
Lech, M., Weidenbusch, M. J., Kulkarni, O. P., Ryu, M., Darisipudi, M. N., Susanti, H. E., Mittruecker, H., Mak, T. W., & Anders, H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121260 · Cited by 59
Self-citationA Network Model to Describe the Terminal Differentiation of B Cells
Méndez, A., & Mendoza, L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004696 · Cited by 60
Unique Features of Naive CD8+ T Cell Activation by IL-2
Cho, J.-H., Kim, H.-O., Kim, K., Yang, D., Surh, C. D., & Sprent, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302293 · Cited by 59
van der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 58
Chang, C.-C., Lorek, J., Sabath, D. E., Li, Y., Chitambar, C. R., Logan, B. R., Kampalath, B., & Cleveland, R. P. (2002) · Blood · doi:10.1182/blood-2002-01-0104 · Cited by 58
Igarashi, K., Ochiai, K., & Muto, A. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm106 · Cited by 58
Zhao, H., Liu, Y., Wang, L., Jin, G., Zhao, X., Xu, J., Zhang, G., Ma, Y., Yin, N., & Peng, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110083 · Cited by 57
O’Reilly, D., Quinn, C. M., El‐Shanawany, T., Gordon, S., & Greaves, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212150200 · Cited by 56
A computational neural approach to support the discovery of gene function and classes of cancer
Azuaje, F. J. (2001) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.914796 · Cited by 57
A role for IRF4 in the development of CLL
Shukla, V., Ma, S., Hardy, R. R., Joshi, S. S., & Lu, R. (2013) · Blood · doi:10.1182/blood-2013-03-492769 · Cited by 57
IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia
Pathak, S., Ma, S., Trinh, L., Eudy, J. D., Wagner, K., Joshi, S. S., & Lu, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022628 · Cited by 55
Akbari, M., Honma, K., Kimura, D., Miyakoda, M., Kimura, K., Matsuyama, T., & Yui, K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301914 · Cited by 54
Self-citationAnipindi, V. C., Bagri, P., Roth, K., Dizzell, S. E., Nguyen, P. V., Shaler, C. R., Chu, D. K., Jiménez-Saiz, R., Liang, H., Swift, S., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005589 · Cited by 60
Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs Is Critical for T Cell Priming
McDaniel, M. M., Kottyan, L. C., Singh, H., & Pasare, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107604 · Cited by 57
Rieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 54
Rosikiewicz, W., Chen, X., Domínguez, P. M., Ghamlouch, H., Aoufouchi, S., Bernard, O., Melnick, A. M., & Li, S. (2020) · Science Advances · doi:10.1126/sciadv.aay5872 · Cited by 61
Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma
Hoefnagel, J. J., Mulder, M. M. S., Dreef, E. J., Jansen, P. M., Pals, S. T., Meijer, C. J. L. M., Willemze, R., & Vermeer, M. H. (2006) · Modern Pathology · doi:10.1038/modpathol.3800650 · Cited by 52
The 6p subtelomere deletion syndrome
DeScipio, C. (2007) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30156 · Cited by 51
Magatti, M., Masserdotti, A., Signoroni, P. B., Vertua, E., Stefani, F. R., Silini, A. R., & Parolini, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01156 · Cited by 52
Schmidt, M., Hochhaus, A., König-Merediz, S. A., Brendel, C. A., Proba, J., Hoppe, G. J., Wittig, B., Ehninger, G., Hehlmann, R., & Neubauer, A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3331 · Cited by 51
Anda, K. S.-D., Gómez‐Martín, D., Díaz‐Zamudio, M., & Alcocer-Varela, J. C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.006 · Cited by 51
Rangaswamy, U. S., & Speck, S. H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003858 · Cited by 50
Honma, K., Kimura, D., Tominaga, N., Miyakoda, M., Matsuyama, T., & Yui, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803171105 · Cited by 51
Self-citationFisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49
Molecular control of Tfh‐cell differentiation by Roquin family proteins
Heissmeyer, V., & Vogel, K. U. (2013) · Immunological Reviews · doi:10.1111/imr.12056 · Cited by 48
Batista, C. R., Li, S. K. H., Xu, L., Solomon, L. A., & DeKoter, R. P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601709 · Cited by 46
Stage-Specific Modulation of IFN-Regulatory Factor 4 Function by Kruppel-Type Zinc Finger Proteins
Gupta, S. K., Anthony, A., & Pernis, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6104 · Cited by 49
Wang, X., Lin, X., Zheng, Z., Lu, B., Jun, W., Tan, A. H., Zhao, M., Loh, J. T., Ng, S. W., Chen, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22242-9 · Cited by 45
Self-citationRaifer, H., Mahiny, A. J., Bollig, N., Petermann, F., Hellhund, A., Kellner, K., Guralnik, A., Reinhard, K., Bothur, E., Huber, M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142155 · Cited by 46
Transcriptional Control of Mature B Cell Fates
Wang, H., Morse, H. C., & Bolland, S. M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.011 · Cited by 50
Induction of Apoptosis in Plasma Cells by B Lymphocyte–Induced Maturation Protein-1 Knockdown
Lin, F.-R., Kuo, H.-K., Ying, H., Yang, F.-H., & Lin, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1868 · Cited by 46
Billingsley, J. M., Rajakumar, P. A., Connole, M., Salisch, N. C., Adnan, S., Kuzmichev, Y. V., Hong, H. S., Reeves, R. K., Kang, H., Li, W., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004740 · Cited by 47
Ortiz, M. A., Light, J. P., Maki, R. A., & Assa‐Munt, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2740 · Cited by 44
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma
Wong, R. W. J., Tan, T. K., Amanda, S., Ngoc, P. C. T., Leong, W. Z., Tan, S. H., Asamitsu, K., Hibi, Y., Ueda, R., Okamoto, T., et al. (2020) · Blood · doi:10.1182/blood.2019002639 · Cited by 46
Kempf, W., Kutzner, H., Cozzio, A., Sander, C. A., Pfaltz, M. C., Müller, B., & Pfaltz, M. C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08566.x · Cited by 43
Teng, Y., Takahashi, Y., Yamada, M., Kurosu, T., Koyama, T., Miura, O., & Miki, T. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2007.05.006 · Cited by 43
Ren, R. (2002) · Oncogene · doi:10.1038/sj.onc.1206090 · Cited by 43
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
Fornés, O., Jia, A., Kuehn, H. S., Min, Q., Pannicke, U., Schleußner, N., Thouenon, R., Yu, Z., Astbury, M. D. L. A., Biggs, C. M., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade7953 · Cited by 45
Transcriptional control of metabolism by interferon regulatory factors
Ahmad, Z., Kahloan, W., & Rosen, E. D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00990-0 · Cited by 45
T cell exhaustion in human cancers
Kang, K., Lin, X., Chen, P., Liu, H., Liu, F., Xiong, W., Li, G., Yi, M., Li, X., Wang, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189162 · Cited by 49
Momtaz, S., Memariani, Z., El‐Senduny, F. F., Sanadgol, N., Golab, F., Katebi, M., Abdolghaffari, A. H., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00361 · Cited by 46
Reguant, A. P., Köhler, R., Mothes, R., Bauherr, S., Hernández, D. C., Uecker, R., Holzwarth, K., Kotsch, K., Seidl, M., Philipsen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21994-8 · Cited by 42
Petit, B., Chaury, M., Clorennec, C. L., Jaccard, A., Gachard, N., Moalic-Judge, S., Labrousse, F., Cogné, M., Bordessoule, D., & Feuillard, J. (2005) · PubMed · Cited by 42
Interferon regulatory factor 4 controls effector functions of CD8 + memory T cells
Harberts, A., Schmidt, C., Schmid, J., Reimers, D., Koch‐Nolte, F., Mittrücker, H., & Raczkowski, F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014553118 · Cited by 45
Self-citationControl of nutrient uptake by IRF4 orchestrates innate immune memory
Santosa, E. K., Kim, H., Rückert, T., Luduec, J.-B. L., Abbasi, A. J., Wingert, C. K., Peters, L., Frost, J. N., Hsu, K. C., Romagnani, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01620-z · Cited by 40
Lee, J., Zhang, J., Chung, Y., Kim, J. H., Kook, C. M., González-Navajas, J. M., Herdman, D. S., Nürnberg, B., Insel, P. A., Corr, M., et al. (2020) · eLife · doi:10.7554/elife.49416 · Cited by 41
Activation and Regulation of Interferon Regulatory Factor 4 in HTLV Type 1-Infected T Lymphocytes
Sharma, S., Mamane, Y., Grandvaux, N., Bartlett, J., Petropoulos, L., Lin, R., & Hiscott, J. B. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/08892220050193047 · Cited by 41
Zhao, W., Liu, Y., Zhang, Q., Wang, L., Lebœuf, C., Zhang, Y., Ma, J., García, J. F., Song, Y., Li, J., et al. (2008) · Blood · doi:10.1182/blood-2007-08-108654 · Cited by 41
Interferon Regulatory Factor 4 (IRF-4) Targets IRF-5 to Regulate Epstein-Barr Virus Transformation
Xu, D., Meyer, F., Ehlers, E., Blasnitz, L., & Zhang, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210542 · Cited by 39
Ortmann, C. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1001 · Cited by 40
Regulation of IRF and STAT Gene Expression by Retinoic Acid
Matikainen, S., Lehtonen, A., Sareneva, T., & Julkunen, I. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050930 · Cited by 40
The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders
Wasco, M. J., Fullen, D. R., Su, L. D., & Ma, L. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.08.013 · Cited by 40
Tonic LAT-HDAC7 Signals Sustain Nur77 and Irf4 Expression to Tune Naive CD4 T Cells
Myers, D. R., Lau, T. A., Markegard, E., Lim, H. W., Kasler, H. G., Zhu, M., Barczak, A. J., Huizar, J., Zikherman, J., Erle, D. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.076 · Cited by 39
Mechanisms of Interferon Action
Leaman, D. W. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_6 · Cited by 39
Cooperative interaction between the DNA-binding domains of PU.1 and IRF4
Yee, A. A., Yin, P., Siderovski, D. P., Mak, T. W., Litchfield, D. W., & Arrowsmith, C. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1838 · Cited by 38
Self-citationThe dynamic functions of IRF4 in B cell malignancies
Maffei, R., Fiorcari, S., Atene, C. G., Martinelli, S., Mesini, N., Pilato, F., Lagreca, I., Barozzi, P., Riva, G., Nasillo, V., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00968-0 · Cited by 37
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis
Jo, S., Schatz, J. H., Acquaviva, J., Singh, H., & Ren, R. (2010) · Blood · doi:10.1182/blood-2009-07-234559 · Cited by 37
Martı́nez, A., Pittaluga, S., Rudelius, M., DAVIES-HILL, T. M., Sebasigari, D., Fountaine, T. J., Hewitt, S. M., Jaffe, E. S., & Raffeld, M. A. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318166f46a · Cited by 38
Wang, S.-F., He, Q.-P., Ma, D.-Y., Xue, Y.-F., & Liu, F. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.07.011 · Cited by 34
CSF-1 in Inflammatory and Arthritic Pain Development
Saleh, R., Lee, M.-C., Khiew, S. H. W., Louis, C., Fleetwood, A. J., Achuthan, A. A., Förster, I., Cook, A. D., & Hamilton, J. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800665 · Cited by 37
Metadata
- Authors
- Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- Nagasaki University (JP)
- B. Patterson, Department of Oncologic Pathology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, M5G 2C1, Canada.
- Venue
- Science
- Published
- 1997-01-24
- Volume
- 275
- Issue
- 5299
- Pages
- 540-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022687427
- Cited by
- 583
- References
- 21
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 12 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 20 · 2016: 15 · 2015: 18 · 2014: 25 · 2013: 32 · 2012: 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IRF4, transcription factors, B cells, T cells, lymphocyte homeostasis, lymphadenopathy, antibody deficiency, antibody response, cytotoxic T lymphocytes, antitumor immunity
- MeSH terms
- Lymphadenopathy, Interferon Regulatory Factor-4, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Homeostasis, Mice, Inbred BALB C, T-Lymphocytes, Cytotoxic, Transcription, Genetic, Mice, SCID, Mice, Knockout, Cell Proliferation, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review